Accuracy of CardioWatch 287-2 During Profound Hypoxia

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 4, 2022

Primary Completion Date

June 18, 2022

Study Completion Date

June 27, 2022

Conditions
Hypoxia
Interventions
DEVICE

CardioWatch 287-2

CardioWatch 287-2 (CW2 Test Device or CW2). This medical device is based on the precursor CardioWatch 287-1 approved by EU-MDR under number 20M00011CRT01, CW2 has two red, two infrared and two green LEDs, and two photosensors compared to its precursor.

Trial Locations (1)

3600

Complementair Medisch Centrum (CMC) Europe, Genk

Sponsors
All Listed Sponsors
collaborator

Ziekenhuis Oost-Limburg

OTHER

lead

Corsano Health B.V.

INDUSTRY

NCT05542732 - Accuracy of CardioWatch 287-2 During Profound Hypoxia | Biotech Hunter | Biotech Hunter